Memoril

Piracetam, the active ingredient in Memoril, is a racetam presented as an oral tablet for oral use. It is employed to enhance cognitive processes in adults with neurological conditions, including cognitive impairment, dyslexia, myoclonus, and vertigo, by modulating neuronal and vascular function. GNH USA supplies Memoril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. Our distribution network adheres to stringent handling standards, providing reliable access to this cognitive enhancer for healthcare providers.

Piracetam is used as a cognitive enhancer targeting neurological conditions that affect learning and memory. - Cognitive impairment: improves attention and memory performance in patients with age‑related or vascular cognitive decline. - Dyslexia: supports reading skills by enhancing neural processing related to language. - Myoclonus: reduces frequency of involuntary muscle jerks in certain neurological disorders. - Vertigo: alleviates balance disturbances by modulating vestibular neuronal activity.

Piracetam is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Nausea: occasional gastrointestinal discomfort. - Insomnia: difficulty initiating or maintaining sleep. - Anxiety: feelings of nervousness or restlessness. - Dizziness: light‑headed sensation, especially at higher doses.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Hematologic changes: thrombocytopenia or leukopenia. - Mood disturbances: depression or suicidal ideation. - Seizure exacerbation: increased frequency in susceptible individuals. - Liver dysfunction: elevated transaminases.

When prescribing Piracetam, clinicians should consider several precautionary measures to ensure patient safety. - Renal function: adjust use in patients with severe renal impairment. - Hepatic function: monitor liver enzymes in individuals with existing liver disease. - Pregnancy: avoid use unless potential benefit justifies potential risk, due to limited data. - Elderly: start with lower doses and monitor for confusion or falls. - Concomitant CNS depressants: use caution as additive effects on sedation may occur. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Piracetam may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk; monitor INR closely. - Anticonvulsants: can reduce seizure control; adjust therapy as needed.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance stimulant effects, leading to nervousness. - Alcohol: combined use may increase sedation or dizziness. - Other nootropics: additive cognitive effects could raise risk of side effects. - Diuretics: may alter electrolyte balance, requiring monitoring.